Use and Cost of a Hypoglossal Nerve Stimulator Device for Obstructive Sleep Apnea

More than 17 million patients in the United States have obstructive sleep apnea,1 a condition associated with sequelae such as daytime somnolence, motor vehicle crashes, and cardiovascular disease.2 Continuous positive airway pressure devices are the first-line treatment for obstructive sleep apnea, although the effectiveness of such treatment is often limited by patient noncompliance.2 Second-line treatments (eg, oral appliances and palatal surgery) exist, but the available evidence offers limited support for such alternatives.2